NEW YORK, May 26 (GenomeWeb News) - Partek announced today that it has licensed its Partek Genomics Suite software to the Chaim Sheba Medical Center and the Weizmann Institute of Science.
The Tel Aviv, Israel-based Sheba Medical Center will use the software to statistically analyze data from its hemato-oncology studies. The Rehovot, Israel-based Weizmann Institute will use it to aid in research in a multitude of areas, including cancer, diabetes, nanoscience, and the environment.
Partek is based in St. Louis, Mo.